Status:
COMPLETED
Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Conditions:
Hypertension
Dyslipidemia
Eligibility:
All Genders
19+ years
Brief Summary
Throughout this study, the efficacy and safety information of Olomax tablets will be collected from 24 weeks to 48 weeks(+8 weeks) The Data collection point is baseline, at more than 24 weeks, at more...
Detailed Description
The study will start after investigator determines the administration of Olomax tablets based on the investigator's judgement and obtaining informed consent from the subject during subject's daily vis...
Eligibility Criteria
Inclusion
- Adults over the age of 19
- Patients eligible for Olomax Tab. prescription in accordance with the approved product manual in Korea
- Patients who are determined to prescribe Olomax Tab. at the discretion of the investigators.
- Antihypertensive agent: Do not include more than 3 agents.
- Anti-abnormal lipidemia: Do not include more than 2 agents.
- Subjects who are already administered beta blocker (BB) or diuretics due to other diseases such as angina, not for the purpose of treating hypertension may be included.
- Consent on the use of information by the patient
Exclusion
- Patients who have already administered olomax tablets.
- Subject who fall under ' Do not administer to the following patients' in the precautions for use
- A patient who does not meet the inclusion/exclusion criteria participates
- The patient withdraws consent for the study
- The administration of the study drug is discontinued
- It is impossible to follow up during the observation period
- The investigator determines that it is no longer feasible to continue the study
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2022
Estimated Enrollment :
5450 Patients enrolled
Trial Details
Trial ID
NCT05184179
Start Date
December 1 2019
End Date
August 16 2022
Last Update
July 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hallym University Dongtan Sacred Heart Hospital
Hwaseong-si, Gyeonggi-do, South Korea, 18450